IXICO plc (LSE:IXI), has announced it will be hosting a Capital Markets Day for analysts and institutional investors.
The company is a global leaderin neuroscience imaging and biomarker analytics, and uses its AI-driven platform to help advance drug development in neurological disorders.
The Capital Markets Day will be on 30 October 2025, from 14:00 TO 17:00, at the offices of Cavendish Capital Markets.
The event will provide the opportunity to hear from IXICO’s CEO and strengthened senior management team, key customers and industry opinion leaders. The agenda will explore the Company’s growth strategy and future direction, the neuroscience landscape trends and expansion opportunities for the Company, IXICO’s technology roadmap and a detailed explanation of IXICO’s AI-driven precision medicine technology platform
Existing and prospective retail investors are welcome to join via a live webcast. The facility to submit questions will be available on this platform.
To register your interest please contact Cavendish Capital Markets on+44 (0) 20 7220 0500 or via email[email protected]
To register for the live webcast investors can sign up to Investor Meet Company for free and add to meet IXICO PLC via: https://www.investormeetcompany.com/ixico-plc/register-investor
This content is for informational purposes only and does not constitute financial, investment, or other professional advice. It should not be considered a recommendation to buy or sell any securities or financial instruments. All investments involve risk, including the potential loss of principal. Past performance is not indicative of future results. You should conduct your own research and consult with a qualified financial advisor before making any investment decisions.
Leave a Reply